Observation and mechanism of transcutaneous auricular vagus nerve stimulation in the treatment of limb motor dysfunction after ischemic stroke

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2023
INTERVENTION: The taVNS group:Transcutaneous aural vagus nerve stimulation +Basic treatment+rehabilitation treatment;The sham taVNS group:taVNS stimulates the vagus‐rich region of the left auricular tail + Basic treatment+rehabilitation treatment;Routine rehabilitation group:Basic treatment+rehabilitation treatment; CONDITION: cerebral arterial thrombosis PRIMARY OUTCOME: WOLF Motor Function Assessment Scale;Fugl‐Meyer scale; SECONDARY OUTCOME: Function Independent Measure, FIM;The SF‐36 scale; INCLUSION CRITERIA: 1. 35 <= 75 years old; 2. Stroke (infarction) occurred for the first time, in the recovery period (course of the disease from 2 months to 6 months), basically stable, unconscious disorder, no obvious language disorder; 3. The diagnosis conforms to the key points of cerebrovascular disease diagnosis adopted by the fourth National Academic Conference on Cerebrovascular Disease in 1995; 4. Unilateral subcortical cerebral infarction (basal ganglia, thalamus, internal capsule, etc.) confirmed by head CT or MRI; 5. Brunnstrom grade of the affected hand 0‐3; 6. There is no metal implant or pacemaker in the body; 7. No previous history of epilepsy or clear cognition does not affect communication and assessment; 8. Informed consent signed by the patient himself or by his immediate family member.
Epistemonikos ID: 05190ccec1f23a222e93a6d30f146d0cc095f0c4
First added on: Feb 20, 2024